Search Result "INR monitoring"
Decentralization and Virtualization of INR-based Anticoagulation ControlDuring the COVID-19 Pandemic
Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 23 Issue: 3 Year: 2023 Page: 177-182
Author(s):
Portable Technologies for Self-Monitoring of Coagulation Time: A Review
Journal: Current Biotechnology
Volume: 1 Issue: 2 Year: 2012 Page: 155-165
Author(s): Lynda Metref,Philippe Renaud
Novel Oral Anticoagulation Laboratory Monitoring, Interaction and Treatment of Complications
Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 15 Issue: 2 Year: 2015 Page: 115-119
Author(s): Aydin Huseynov,Stefan Baumann,Ibrahim El-Battrawy,Ibrahim Akin
Azathioprine and Acenocoumarol Drug Interaction in Patients withCrohnâs Disease: A Case Report
Journal: Current Drug Safety
Volume: 18 Issue: 2 Year: 2023 Page: 267-269
Author(s):
Antithrombotic Options for Atrial Fibrillation in 2012
Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 12 Issue: 1 Year: 2012 Page: 1-5
Author(s): Jennifer Rude,Karla Quevedo,Lissette Rodriguez de Armas,Debabrata Mukherjee
Bleeding Complications in a Patient After the Unexpected Interactionbetween Valproic Acid and Phenprocoumon
Journal: Current Drug Safety
Volume: 19 Issue: 1 Year: 2024 Page: 142-144
Author(s): Fleur van Gelder,Abraham J. Valkenburg,Jan G. Maring,Elise J. Smolders
Primary Prevention of Ischaemic Stroke in Atrial Fibrillation: New Oral Anticoagulant Drugs for all?
Journal: Current Vascular Pharmacology
Volume: 12 Issue: 3 Year: 2014 Page: 373-383
Author(s): James Foley,Paulus Kirchhof,Gregory Y. H. Lip
NOAC or warfarin for Atrial Fibrillation: does time in therapeutic range matter?
Journal: Recent Advances in Cardiovascular Drug Discovery (Discontinued)
Volume: 10 Issue: 1 Year: 2015 Page: 60-64
Author(s): Ioannis Merinopoulos,Paul Venables,Isobel Chalmers,Vassilios Vassiliou
Is Anticoagulation with Novel Oral Anticoagulants an Effective Treatment for Tuberculosis Patients not Achieving a Therapeutic Range with Vitamin K Antagonists? A Systematic Review
Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 17 Issue: 2 Year: 2017 Page: 105-110
Author(s): Marco Fiore,Alberto Enrico Maraolo,Paolo Chiodini,Claudio Cerchione,Ivan Gentile,Guglielmo Borgia,Maria Caterina Pace
Laboratory Monitoring or Measurement of Direct Oral Anticoagulants (DOACs): Advantages, Limitations and Future Challenges
Journal: Current Drug Metabolism
Volume: 18 Issue: 7 Year: 2017 Page: 598-608
Author(s): Emmanuel J. Favaloro,Leonardo Pasalic,Jennifer Curnow,Giuseppe Lippi